Juli Teague

Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy

Peter W. Hunt, Jeffrey N. Martin, Elizabeth Sinclair et al. · The Journal of Infectious Diseases · 2011 · 346 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Discovery of a potent and selective Aurora kinase inhibitor

Johan D. Oslob, M.J. Romanowski, Darin A. Allen et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 108 citations · Full text

Medicine, Medicinal Chemistry, Oncology +9

Toll-like Receptor 3–Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance

Arnold I. Chin, Andrea K. Miyahira, Anthony J. Covarrubias et al. · Cancer Research · 2010 · 105 citations · Full text

Life Sciences, Immunology, Oncology +17

SNS-314, a pan-Aurora kinase inhibitor, shows potent anti-tumor activity and dosing flexibility in vivo

Jennifer P. Arbitrario, Brian J. Belmont, Marc Evanchik et al. · Cancer Chemotherapy and Pharmacology · 2009 · 67 citations

Medicine, Oncology, Pharmacology +9

Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow

Steven G. DuBois, C. Lorrie Epling, Juli Teague et al. · Pediatric Blood & Cancer · 2009 · 61 citations · Full text

Medicine, Cell Biology, Oncology +15